Dong-A Pharmaceutical announced on July 10 that it has launched Turbinew Double Action Aerosol, an easy-to-spray athlete's foot treatment.


Athlete's foot is a superficial fungal infection caused by dermatophytes. These fungi tend to proliferate rapidly during the hot and humid summer months. If the initial symptom of itching is not properly treated, the condition can worsen and become chronic.

Dong-A Pharmaceutical's easy-to-spray athlete's foot treatment, 'Tervine Double Action Aerosol.' Dong-A Pharmaceutical

Dong-A Pharmaceutical's easy-to-spray athlete's foot treatment, 'Tervine Double Action Aerosol.' Dong-A Pharmaceutical

View original image

Turbinew Double Action Aerosol, newly introduced by Dong-A Pharmaceutical, is a spray-type treatment that differs from traditional ointment formulations. Because it is in spray form, it can be easily used on areas that are difficult to apply ointment to, and the 360-degree spray nozzle allows for convenient application from any angle.


The product contains a quadruple complex of active ingredients (▲terbinafine ▲diphenhydramine ▲enoxolone ▲lidocaine), which help treat the cause of athlete's foot and relieve symptoms such as itching.


Turbinew Double Action Aerosol is an over-the-counter medication and can be purchased at local pharmacies.


A Dong-A Pharmaceutical representative stated, "As consistent management is important for athlete's foot, we have introduced a new spray-type product to enhance user convenience,” adding, “We hope that Turbinew Double Action Aerosol will become a new treatment option that can be easily used even on hard-to-reach areas."



Meanwhile, Dong-A Pharmaceutical's athlete's foot treatment brand, Turbinew, offers a product lineup that includes the gel-type ▲Turbinew Gel ▲Turbinew Double Action Gel, the liquid-type ▲Turbinew Once External Solution, and the spray-type Turbinew Double Action Aerosol. Notably, Turbinew Gel, which features a trans-gel that aids in skin absorption of the drug, ranked No. 1 in sales in the domestic athlete's foot treatment market for four consecutive years from 2020 to 2023, according to IQVIA data.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing